The Clinical Trials Reporting
Program (CTRP) Database (NCI)
Reinstatement with change of a previously approved collection
No
Regular
04/01/2026
Requested
Previously Approved
36 Months From Approved
24,000
0
18,000
0
0
0
This is a request for OMB to approve a
Reinstatement With Change of the “The Clinical Trials Reporting
Program (CTRP) Database” for an additional three years. CTRP is an
electronic resource that serves as a single, definitive source of
information about all NCI-supported clinical research. This
resource allows the NCI to consolidate reporting, aggregate
information, and reduce redundant submissions. Information is
submitted by clinical research administrators as designees of
clinical investigators who conduct NCI-supported clinical research.
The designees can electronically access the CTRP website to
complete the initial trial registration for each protocol.
Subsequent to registration, up to four amendments and four study
subject accrual updates occur per protocol annually. This request
is for a Reinstatement With Change of information
collection.
This is a Reinstatement With
Change with several notable changes listed in A.15 of the
Supporting Statement A.
$6,412,305
No
Yes
Yes
No
No
No
No
Mikia Currie 3014350941
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
04/01/2026
Something went wrong when
downloading this file. If you have any questions, please send an
email to [email protected].